logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Trial reports highest-ever 5-year OS in advanced NSCLC

5-year OS was 32.1% with standard-dose radiation therapy and concurrent chemotherapy.